INVO Bio (INVO) Enterprise Value to EBITDA Ratio
The price indicator on the EV/EBITDA chart on the GURU.Markets platform is , illustrating the valuation of INVO Bioscience, Inc. (INVO). INVO Bioscience, Inc. (INVO) develops automated incubators for in vivo embryo maturation, streamlining laboratory operations. The business aims to make IVF more accessible to the masses through the INVOcell system. The sector's specifics provide resilience to macroeconomic fluctuations, turning the asset into a reliable defensive tool.
Comprehensive metric breakdowns and analytics for invobioscience.com (INVO)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio INVO Bioscience, Inc.|INVO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity INVO Bioscience|INVO - Company Total Debt|Debts to Book Capitalization INVO Bioscience, Inc.|INVO - Long-Term Debt|Company Short-Term Debts INVO Bioscience|Quick Ratio invobioscience.com
- financial results and valuation multiples details:
INVO - Net Financial Result|Projected Future Earnings INVO Bioscience, Inc.|INVO - Price to Earnings Ratio|Forward P/E Multiple INVO Bioscience|INVO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Bioscience, Inc.|INVO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months INVO Bioscience|INVO - Earnings per share for the trailing year|Quarterly EPS earnings growth invobioscience.com|INVO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year INVO Bioscience, Inc.
Analysis of all company metrics:INVO Bio INVO
The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit, promptly reflecting the impact of debt load and tax obligations on capitalization. This indicator allows for the determination of an asset's real price by eliminating market noise and protecting the investor from inflationary losses through fundamental balance. For INVO Bioscience, the expansion of its clinic network and integration with NAYA Biosciences drive the EV/EBITDA dynamics over the given time interval.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|LFWD - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Autonomix Medical Inc.|Enterprise Value to Operating Income Before Depreciation IVF (INVO Bioscience)|Enterprise Value to EBITDA Ratio BBLG (Bone Biologics Corporation)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AXNX (Axonics, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BIOLASE, Inc. BIOL|Dynatronics Corp (DYNT) - Company Value to EBITDA|FNA: Enterprise Value to EBITDA Ratio
